Legal and Ethical Considerations for Offering Clinical Trial Recruitment Payments and Enrollment Incentives
Update Magazine | Summer 2024
“Modernized” Food Manufacturing Enforcement: Trends in FDA Warning Letters
“Modernized” Food Manufacturing Enforcement: Trends in FDA Warning Letters By Joshua Oyster & Chadli Pittman I. Introduction The Federal Food, Drug, and Cosmetic Act (FDCA), as amended by the FDA Food Safety Modernization Act (FSMA),[1] empowers the U.S. Food and Drug Administration (FDA) to regulate the safety and quality of the nation’s [...]
FDA Law and the Psychedelic Renaissance
Update Magazine | Spring 2024
Letter to the Editor: FDA Citizen Petition Seeks Historical Reckoning to Require the Labeling of Gluten on All Food Packages in the United States
Update Magazine | Spring 2024
Chevron Deference on the Brink: Small Fish May Mean Big Changes For FDA
Update Magazine | Spring 2024
Leqembi and the Accelerated Approval Pathway
Update Magazine | Spring 2024
The Curious Case of Aspartame: How the Same Evidence Can Yield Seemingly Different Conclusions
Update Magazine | Spring 2024
Tech Support: FDA’s Evolving Regulatory Plan for Drug- and Device-Enabling Software
Update Magazine | Winter 2023
Risk Sharing Agreements in Brazil
Update Magazine | Winter 2023
Implementing MoCRA: FDA Releases New Draft Guidances on Insanitary Conditions for Tattoo Ink and Cosmetic Product Registration & Listing
Update Magazine | Winter 2023
